Kapoor GS - Search Results

1

Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.

Walsh AM, Kapoor GS, Buonato JM, Mathew LK, Bi Y, Davuluri RV, Martinez-Lage M, Simon MC, O'Rourke DM, Lazzara MJ. Walsh AM, et al. Among authors: kapoor gs. Mol Cancer Res. 2015 Aug;13(8):1227-37. doi: 10.1158/1541-7786.MCR-14-0183-T. Epub 2015 May 1. Mol Cancer Res. 2015. PMID: 25934697 Free PMC article.

2

Mitogenic signaling cascades in glial tumors.

Kapoor GS, O'Rourke DM. Kapoor GS, et al. Neurosurgery. 2003 Jun;52(6):1425-34; discussion 1434-5. doi: 10.1227/01.neu.0000065135.28143.39. Neurosurgery. 2003. PMID: 12762887 Review.

3

Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches.

Kapoor GS, O'Rourke DM. Kapoor GS, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):330-42. doi: 10.4161/cbt.2.4.507. Cancer Biol Ther. 2003. PMID: 14508101 Free article. Review.

4

Constitutive EGFR signaling confers a motile phenotype to neural stem cells.

Boockvar JA, Kapitonov D, Kapoor G, Schouten J, Counelis GJ, Bogler O, Snyder EY, McIntosh TK, O'Rourke DM. Boockvar JA, et al. Mol Cell Neurosci. 2003 Dec;24(4):1116-30. doi: 10.1016/j.mcn.2003.09.011. Mol Cell Neurosci. 2003. PMID: 14697673

5

Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.

Kapoor GS, Zhan Y, Johnson GR, O'Rourke DM. Kapoor GS, et al. Mol Cell Biol. 2004 Jan;24(2):823-36. doi: 10.1128/MCB.24.2.823-836.2004. Mol Cell Biol. 2004. PMID: 14701753 Free PMC article.

6

Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.

Kapoor GS, Kapitonov D, O'Rourke DM. Kapoor GS, et al. Cancer Res. 2004 Sep 15;64(18):6444-52. doi: 10.1158/0008-5472.CAN-04-0256. Cancer Res. 2004. PMID: 15374953

7

EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.

Kapoor GS, Christie A, O'Rourke DM. Kapoor GS, et al. Cancer Biol Ther. 2007 Apr;6(4):571-9. doi: 10.4161/cbt.6.4.3852. Cancer Biol Ther. 2007. PMID: 17457042 Free article.

8

Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging.

Whitmore RG, Krejza J, Kapoor GS, Huse J, Woo JH, Bloom S, Lopinto J, Wolf RL, Judy K, Rosenfeld MR, Biegel JA, Melhem ER, O'Rourke DM. Whitmore RG, et al. Among authors: kapoor gs. J Neurosurg. 2007 Sep;107(3):600-9. doi: 10.3171/JNS-07/09/0600. J Neurosurg. 2007. PMID: 17886561

9

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.

Kapoor GS, Gocke TA, Chawla S, Whitmore RG, Nabavizadeh A, Krejza J, Lopinto J, Plaum J, Maloney-Wilensky E, Poptani H, Melhem ER, Judy KD, O'Rourke DM. Kapoor GS, et al. J Neurooncol. 2009 May;92(3):373-86. doi: 10.1007/s11060-009-9880-x. Epub 2009 Apr 9. J Neurooncol. 2009. PMID: 19357963

10

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells.

Ayuso-Sacido A, Moliterno JA, Kratovac S, Kapoor GS, O'Rourke DM, Holland EC, García-Verdugo JM, Roy NS, Boockvar JA. Ayuso-Sacido A, et al. Among authors: kapoor gs. J Neurooncol. 2010 May;97(3):323-37. doi: 10.1007/s11060-009-0035-x. Epub 2009 Oct 24. J Neurooncol. 2010. PMID: 19855928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters